Efficacy of Perioperative Chemotherapy for Resectable Pancreatic Adenocarcinoma: A Phase 2 Randomized Clinical Trial

IMPORTANCE: Clinical outcomes after curative treatment of resectable pancreatic ductal adenocarcinoma (PDA) remain suboptimal. To assess the potential of early control of systemic disease with multiagent perioperative chemotherapy, we conducted a prospective trial. OBJECTIVE: To determine 2-year ove...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Oncol
Main Authors: Sohal, Davendra P. S., Duong, Mai, Ahmad, Syed A., Gandhi, Namita S., Beg, M. Shaalan, Wang-Gillam, Andrea, Wade, James L., Chiorean, E. Gabriela, Guthrie, Katherine A., Lowy, Andrew M., Philip, Philip A., Hochster, Howard S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7821078/
https://ncbi.nlm.nih.gov/pubmed/33475684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2020.7328
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados